Ergoteles’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Ergoteles’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-277,626	Closed	-$6.69M	–	1718
2023 Q1	$6.69M	Buy	+277,626	New	+$3.48M	0.26%	65

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ergoteles's PRVB Position: Q2 2023 in Review

Ergoteles sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 277,626 shares — an estimated $6.69M sold.

Ergoteles first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $6.69M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Ergoteles reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 277,626 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $6.69M.
Ergoteles first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Ergoteles's Provention Bio, Inc. Common Stock position peaked at $6.69M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.